Evidence map›Paper›PMID 24204141›Full record

ArticleInternational journal of nanomedicine2013

Induction of apoptosis in cancer cells by NiZn ferrite nanoparticles through mitochondrial cytochrome C release.

Mothanna Sadiq Al-Qubaisi, Abdullah Rasedee, Moayad Husein Flaifel, Sahrim Hj Ahmad, Samer Hussein-Al-Ali, Mohd Zobir Hussein, Zulkarnain Zainal, Fatah H Alhassan, Yun H Taufiq-Yap, Eltayeb E M Eid and 4 more

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Molecular & cellular oncology · 2024
    Article
  4. Newly Synthesized CoFeInternational journal of molecular sciences · 2023
    Article
  5. Article
  6. Article
  7. Inclusion complex of clausenidin with hydroxypropyl-β-cyclodextrin: Improved physicochemical properties and anti-colon cancer activity.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Mothanna Sadiq Al-QubaisiInstitute of Bioscience, Universiti Putra Malaysia, Selangor, Malaysia.
Abdullah Rasedee
Moayad Husein Flaifel
Sahrim Hj Ahmad
Samer Hussein-Al-Ali
Mohd Zobir Hussein
Zulkarnain Zainal
Fatah H Alhassan
Yun H Taufiq-Yap
Eltayeb E M Eid
Ismail Adam Arbab
Bandar A Al-Asbahi
Thomas J Webster
Mohamed Ezzat El Zowalaty
Universiti Putra Malaysia · MYNational University of Malaysia · MYJazan University · SAKing Abdulaziz University · SAQassim University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The long-term objective of the present study was to determine the ability of NiZn ferrite nanoparticles to kill cancer cells. NiZn ferrite nanoparticle suspensions were found to have an average hydrodynamic diameter, polydispersity index, and zeta potential of 254.2 ± 29.8 nm, 0.524 ± 0.013, and -60 ± 14 mV, respectively. We showed that NiZn ferrite nanoparticles had selective toxicity towards MCF-7, HepG2, and HT29 cells, with a lesser effect on normal MCF 10A cells. The quantity of Bcl-2, Bax, p53, and cytochrome C in the cell lines mentioned above was determined by colorimetric methods in order to clarify the mechanism of action of NiZn ferrite nanoparticles in the killing of cancer cells. Our results indicate that NiZn ferrite nanoparticles promote apoptosis in cancer cells via caspase-3 and caspase-9, downregulation of Bcl-2, and upregulation of Bax and p53, with cytochrome C translocation. There was a concomitant collapse of the mitochondrial membrane potential in these cancer cells when treated with NiZn ferrite nanoparticles. This study shows that NiZn ferrite nanoparticles induce glutathione depletion in cancer cells, which results in increased production of reactive oxygen species and eventually, death of cancer cells.

Indexed as

Antineoplastic AgentsApoptosisbcl-2-Associated X ProteinCell Line, TumorCell ProliferationCytochromes cFerric CompoundsGlutathioneHumansMalondialdehydeMembrane Potential, MitochondrialMetal NanoparticlesNickelProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesTumor Suppressor Protein p53Antineoplastic Agentsbcl-2-Associated X ProteinCytochromes cFerric CompoundsGlutathioneMalondialdehydeNickelnickel-zinc ferriteProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesTumor Suppressor Protein p53Zinc Compoundscancer cellscytochrome Cmitochondrial membrane potentialNiZn ferrite nanoparticlesp53reactive oxygen species

Identifiers

PMID24204141
PMCPMC3817022
OpenAlexW2023323976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.